Noema Pharma, a Swiss biotech targeting debilitating central nervous system (CNS) disorders, has announced the successful ...

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced the ...

EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Noema Pharma ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland is developing a ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Noema was founded in 2019 with a seed investment from Sofinnova partners and is led by chief executive Luigi Costa, former CEO of Nordic Nanovector and a senior executive at Onyx Pharma ...

Swiss biotech Noema has raised 54 million Swiss francs ... four phase 2 drugs brought in from Roche after the big Swiss pharma decided somebody else should take the risk of developing them.

This week on Pipeline Moves, we kick off by looking at a Phase II trial of Noema Pharma’s NOE-105 in stuttering which completed. Meanwhile, Lyvgen Biopharma terminated a trial of its pipeline ...

PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies. PurpleLab® stands out from ...

BASEL, Switzerland, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Noema Pharma AG, a clinical-stage neuroscience-based company, today announced the first patients have been dosed in a global Phase 2b study ...